Table 7
Prevalence and YLDs, with percentage of total, for heart failure by cause in 1990 and 2013, and prevalence by severity in 2013
| Total prevalence (× 1000) | Total YLDs (× 1000) | Prevalence by severity in 2013 (× 1000) | |||||
|---|---|---|---|---|---|---|---|
| 1990 | 2013 | 1990 | 2013 | Mild | Moderate | Severe | |
| Ischaemic heart disease | 10 298·9 (32·79%) | 20 372·6 (33·04%) | 1114·3 (25·51%) | 2216·1 (25·89%) | 5055·3 (8·20%) | 4131·3 (6·70%) | 11 186·1 (18·14%) |
| Hypertensive heart disease | 5128·4 (16·33%) | 10 906·9 (17·69%) | 559·1 (12·80%) | 1193·9 (13·95%) | 2707·3 (4·39%) | 2215·8 (3·59%) | 5983·8 (9·70%) |
| Other cardiovascular and circulatory diseases | 4117·6 (13·11%) | 9542·1 (15·48%) | 448·9 (10·28%) | 1042·6 (12·18%) | 2356·1 (3·82%) | 1945·8 (3·16%) | 5240·3 (8·50%) |
| Cardiomyopathy and myocarditis | 4077·6 (12·98%) | 7629·9 (12·37%) | 451·9 (10·35%) | 847·9 (9·91%) | 1880·1 (3·05%) | 1553·8 (2·52%) | 4196·1 (6·81%) |
| Chronic obstructive pulmonary disease | 3036·5 (9·67%) | 5846·4 (9·48%) | 1222·0 (27·98%) | 2366·4 (27·65%) | 1438·2 (2·33%) | 1201·5 (1·95%) | 3206·8 (5·20%) |
| Rheumatic heart disease | 2837·8 (9·04%) | 4274·0 (6·93%) | 316·2 (7·24%) | 473·2 (5·53%) | 1055·5 (1·71%) | 873·1 (1·42%) | 2345·5 (3·80%) |
| Endocrine, metabolic, blood, and immune disorders | 338·2 (1·08%) | 852·4 (1·38%) | 39·2 (0·90%) | 97·3 (1·14%) | 208·1 (0·34%) | 1742 (0·28%) | 470·1 (0·76%) |
| Congenital heart anomalies | 495·9 (1·58%) | 621·7 (1·01%) | 60·0 (1·37%) | 74·8 (0·87%) | 152·2 (0·25%) | 126·8 (0·21%) | 342·7 (0·56%) |
| Iron-deficiency anaemia | 373·2 (1·19%) | 446·6 (0·72%) | 43·1 (0·99%) | 51·2 (0·60%) | 110·1 (0·18%) | 90·8 (0·15%) | 245·7 (0·40%) |
| Chagas disease | 280·1 (0·89%) | 383·9 (0·62%) | 31·4 (0·72%) | 42·9 (0·50%) | 95·3 (0·15%) | 78·3 (0·13%) | 210·3 (0·34%) |
| Endocarditis | 136·2 (0·43%) | 250·2 (0·41%) | 15·7 (0·36%) | 29·1 (0·34%) | 61·6 (0·10%) | 50·9 (0·08%) | 137·6 (0·22%) |
| Other haemoglobinopathies and haemolytic anaemias | 93·0 (0·30%) | 216·6 (0·35%) | 11·0 (0·25%) | 25·2 (0·29%) | 52·9 (0·09%) | 44·3 (0·07%) | 119·4 (0·19%) |
| Thalassaemias | 96·4 (0·31%) | 117·8 (0·19%) | 11·9 (0·27%) | 14·5 (0·17%) | 29·3 (0·05%) | 23·8 (0·04%) | 64·7 (0·10%) |
| Interstitial lung disease and pulmonary sarcoidosis | 51·3 (0·16%) | 102·1 (0·17%) | 24·3 (0·56%) | 48·1 (0·56%) | 25·2 (0·04%) | 20·8 (0·03%) | 56·2 (0·09%) |
| Other pneumoconiosis | 16·2 (0·05%) | 37·7 (0·06%) | 7·8 (0·18%) | 18·0 (0·21%) | 9·3 (0·02%) | 7·7 (0·01%) | 20·7 (0·03%) |
| Glucose-6-phosphate dehydrogenase deficiency | 8·1 (0·03%) | 20·4 (0·03%) | 1·0 (0·02%) | 2·5 (0·03%) | 5·0 (0·01%) | 4·1 (0·01%) | 11·3 (0·02%) |
| Silicosis | 10·8 (0·03%) | 16·2 (0·03%) | 5·2 (0·12%) | 7·8 (0·09%) | 4·0 (0·01%) | 3·3 (0·01%) | 8·9 (0·01%) |
| Coal workers’ pneumoconiosis | 5·8 (0·02%) | 9·0 (0·01%) | 2·8 (0·06%) | 4·3 (0·05%) | 2·2 (0·00%) | 1·8 (0·00%) | 5·0 (0·01%) |
| Iodine deficiency | 4·3 (0·01%) | 6·9 (0·01%) | 0·6 (0·01%) | 0·9 (0·01%) | 1·7 (0·00%) | 1·4 (0·00%) | 3·8 (0·01%) |
| Asbestosis | 2·4 (0·01%) | 4·1 (0·01%) | 1·1 (0·03%) | 2·0 (0·02%) | 1·0 (0·00%) | 0·8 (0·00%) | 2·2 (0·00%) |
| Total prevalence | 31 408·5 (100·00%) | 61 657·6 (100·00%) | .. | .. | 15 250·2 (24·73%) | 12 550·3 (20·35%) | 33 857·1 (54·91%) |
| Total YLDs | .. | .. | 4367·4 (100·00%) | 8558·7 (100·00%) | 1069·3 (12·49%) | 1211·1 (14·15%) | 6278·2 (73·35%) |